Senseonics, Incorporated


Senseonics is a medical technology company focused on developing and commercializing long-term implantable continuous glucose monitoring (CGM) systems to improve the lives of people with diabetes. Their Eversense and Eversense XL CGM systems are designed to continually and accurately measure glucose levels via an under-the-skin sensor, a rechargeable smart transmitter, and a mobile app, with a duration of up to 90 and 180 days respectively.

Industries

biotechnology
health-care
medical
medical-device
sensor
wearables

Nr. of Employees

medium (51-250)

Senseonics, Incorporated

Germantown, Maryland, United States, North America


Products

Long-term implantable continuous glucose monitoring system (90-day and 180-day versions)

An implantable continuous glucose monitoring platform composed of an under-skin sensor, a removable and rechargeable transmitter, and a companion mobile application for real-time glucose monitoring over multi-month wear durations.


Services

Clinical evaluation and publication support

Design, execution and publication of clinical studies assessing accuracy and safety of implantable glucose monitoring systems; support for clinical evidence generation and dissemination.

Expertise Areas

  • Implantable continuous glucose monitoring
  • Clinical trial execution and publication
  • Medical device R&D and engineering
  • Regulatory compliance and market authorization
  • Show More (4)

Key Technologies

  • Long-term implantable biosensors
  • Subcutaneous glucose sensing
  • Miniaturized implantable electronics
  • Rechargeable removable transmitters
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.